Evrofarma SA reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 23.56 million compared to EUR 19.7 million a year ago. Net income was EUR 1.42 million compared to net loss of EUR 0.022 million a year ago.

Basic earnings per share from continuing operations was EUR 0.1035 compared to basic loss per share from continuing operations of EUR 0.0016 a year ago.